The prevention of prostate cancer--the dilemma continues

N Engl J Med. 2003 Jul 17;349(3):297-9. doi: 10.1056/NEJMe038109. Epub 2003 Jun 24.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • 5-alpha Reductase Inhibitors*
  • Antineoplastic Agents, Hormonal / adverse effects
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Finasteride / adverse effects
  • Finasteride / therapeutic use*
  • Humans
  • Male
  • Prostatic Neoplasms / chemically induced
  • Prostatic Neoplasms / pathology
  • Prostatic Neoplasms / prevention & control*
  • Risk Assessment

Substances

  • 5-alpha Reductase Inhibitors
  • Antineoplastic Agents, Hormonal
  • Finasteride